We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Sustainability Through Innovation
Sustainability Through Innovation
Blog

With growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.

Read More

Students Get Hands-on with Mass Spectrometry
Students Get Hands-on with Mass Spectrometry
Blog

We spoke to Dr Jonathan Jones from Waters Corporation, to learn more about the new initiative that they and Swansea University are leading to give students hands-on experience of mass spectrometry.

Read More

Monitoring Pulmonary Exacerbation in Cystic Fibrosis: The Hunt for Urine-based Biomarkers Begins
The Search Begins: Urinary Biomarkers that Indicate Pulmonary Exacerbation in Cystic Fibrosis
Blog

A clinical trial has been launched to identify urine-based biomarkers which indicate lung flare-ups in cystic fibrosis. Researchers believe point-of-care monitoring will help people get treatment faster, improve patient outcomes and reduce healthcare costs.

Read More

Why is China Becoming a Microfluidics Manufacturing Superpower?
Why is China Becoming a Microfluidics Manufacturing Superpower?
Blog

Many Chinese microfluidics companies are emerging and expanding, and it could be game-changing for the industry. We spoke with Yole Développement analyst, Sébastien Clerc, to learn more.

Read More

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain
Say Hello to Regenerative Medicine and Goodbye to Back Pain
Blog

Degenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.

Read More

A Move Towards Precise Management of Bacterial Infections
A Move Towards Precise Management of Bacterial Infections
Blog

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.

Read More

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer
Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer
Blog

During this year’s AACR Annual Meeting we spoke to Dr. Delphine Lissa and Dr. Ana Robles from the National Cancer Institute to learn more about the team’s most recent study on the use of two specific biomarkers for risk stratification of stage I lung cancer patients.

Read More

Antibody Engineering: Driving Therapeutic Discovery and Diagnostics Forward
Antibody Engineering: Driving Therapeutic Discovery and Diagnostics Forward
Blog

We recently spoke to GenScript’s VP of Marketing, Eric Wang, to learn more about the company’s mission to “make people and nature healthier through biotechnology”. Eric discusses the key phases of antibody therapeutic discovery and development, GenScript’s role in advancing drug discovery research, and tells us about the company’s recently launched custom rabbit monoclonal antibody service.

Read More

Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis
Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis
Blog

To learn more about ContextVision, their move into the field of digital pathology, and how INIFY™ could help benefit pathologists and patients, we spoke to Lena Kajland Wilén, Director Business Unit Digital Pathology.

Read More

HPV-Positive Oropharyngeal Cancers: Predicting Treatment Response Using ddPCR
HPV-Positive Oropharyngeal Cancers: Predicting Treatment Response Using ddPCR
Blog

During this year’s AACR Annual Meeting we spoke to Julianna Supplee, Research Technician at the Robert and Renée Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute, to learn more about the team’s most recent study on the use of plasma HPV cell-free DNA as an early predictor of treatment response in patients with advanced oropharyngeal cancer.

Read More